IPROVIDE PHYSIO LIMITED

Company number 08872141 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£40k -£20k £0 £20k £40k £60k £80k £100k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £98,423 Total assets 2017: £83,275 Total assets 2018: £43,530 Total assets 2019: £55,583 Total assets 2020: £35,373 Total assets 2021: £57,929 Total assets 2022: £31,990 Total assets 2023: £21,710 Total assets 2024: £16,285 Total assets 2025: £13,481 Total assets Net assets 2018: £39,776 Net assets 2019: £46,737 Net assets 2020: £30,755 Net assets 2021: £17,721 Net assets 2022: £4,965 Net assets 2023: £3,660 Net assets 2024: £6,054 Net assets 2025: £2,426 Net assets Total liabilities 2016: -£17,887 Total liabilities 2017: -£6,245 Total liabilities 2018: -£3,754 Total liabilities 2019: -£8,844 Total liabilities 2020: -£4,618 Total liabilities 2021: -£35,000 Total liabilities 2022: -£32,800 Total liabilities 2023: -£19,210 Total liabilities 2024: -£12,155 Total liabilities 2025: -£7,233 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 0 1 2024 2025 2024: 1 2025: 1

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 11 years

Latest accounts (2025-01-31): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-01-31 £13,481 -£7,233 £2,426 £1,911 1
2024-01-31 £16,285 -£12,155 £6,054 £3,964 1
2023-01-31 £21,710 -£19,210 £3,660 £6,933
2022-01-31 £31,990 -£32,800 £4,965 £13,732
2021-01-31 £57,929 -£35,000 £17,721 £38,254
2020-01-31 £35,373 -£4,618 £30,755 £9,924
2019-01-31 £55,583 -£8,844 £46,737 £23,490
2018-01-31 £43,530 -£3,754 £39,776 £19,723
2017-01-31 £83,275 -£6,245
2016-01-31 £98,423 -£17,887
2015-01-31 £59,656 -£12,229 £56,965

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.